Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001330071 | SCV001521665 | uncertain significance | Smith-Magenis syndrome | 2019-03-02 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001863213 | SCV002109154 | benign | not provided | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003405556 | SCV004115038 | uncertain significance | RAI1-related disorder | 2024-01-12 | no assertion criteria provided | clinical testing | The RAI1 c.3883C>T variant is predicted to result in the amino acid substitution p.Pro1295Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.028% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |